HL
Hilleman Laboratories at World Vaccine Congress Europe 2026
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
Hilleman Laboratories takes part in 3 sessions at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits. Its sessions focus on where vaccines are made and developed, from global manufacturing in a fractured world to outbreak-ready vaccine partnerships. One makes the case that low- and middle-income countries will drive the next decade of vaccine development.
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
HL Hilleman Laboratories Singapore, Singapore | |
Vaccine research and development organization, founded by MSD and Wellcome, developing affordable vaccines for low- and middle-income countries. | Booth Exhibiting (no floor booth listed) Talk Tue Oct 20 11:30 Working Group: Forging Outbreak-ready Vaccine Partnerships Infectious disease & AMRSupply, safety & access Talk Wed Oct 21 09:00 The New Geopolitics of Vaccines: Global Vaccine Manufacturing in a Fractured World How governments and industry can keep vaccines flowing fairly across borders in an emergency as countries push to make vaccines at home. Supply, safety & accessBioprocess & manufacturing Talk Wed Oct 21 12:15 Panel: The New Geography of Vaccine Innovation: Why the Next Decade of Vaccine Development Will Be Driven by LMICs Why low- and middle-income countries are becoming vaccine innovators, not just trial sites, and what funding and regional regulatory cooperation they need. |
Instantly find 20 buyers from Hilleman Laboratories
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the World Vaccine Congress. Submit a correction